Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updates in
BRAF V600E
-Mutated mCRC
9
Mins
March 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
Read more
14
Mins
3rd February 2022
Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine
This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…
10
Mins
21st January 2022
Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer
Lung cancer has a devastating global impact, claiming almost 2 million lives in 2020.1 Despite advances in treatment, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.
5
Mins
5th January 2022
Thyroid Papillary Carcinoma and Hyperthyroidism: A Case Study
Thyroid cancer is the most common malignant endocrine tumour in the world, but it only accounts for 1% of all cancers…
8
Mins
24th December 2021
Why EGFR Exon 21 L858R Mutations Should Be Treated Differently
The two most common EGFR mutations differ in their kinase domain structures at different sites, resulting in differential sensitivity to EGFR
6
Mins
9th December 2021
Neurofibromatosis Type 1: Burden of Disease in Patients with Plexiform Neurofibromas
NF1 is an autosomal dominant disorder, arising from a mutation in the gene that encodes neurofibromin. It is a tumour-predisposing…
6
Mins
9th December 2021
Management and Multi-specialty Approach in the Evolving Treatment Landscape of Neurofibromatosis Type 1 Plexiform Neurofibromas
Neurofibromatosis Type 1 (NF1) is a rare disease, occurring in approximately 1 in 3,000 people. Among the numerous manifestations…
15
Mins
18th November 2021
Multidisciplinary Team Approach in Cancer Care: A Review of The Latest Advancements
The management of patients with cancer is complex and requires contribution from a range of healthcare professionals working alongside specialist oncology consultants to address patients’ needs and optimise outcomes.
10
Mins
2nd November 2021
Navigating the Current Treatment Landscape in Oesophageal Cancer with an Eye Toward the Future
The symposium featured three talks and a live Q&A session. First, the current patient journey and standards of care in oesophageal cancer…
Loading posts...
« Previous
1
…
5
6
7
8
9
…
26
Next »